LAUSR

The development of nanotechnology has led to the increased production of zinc oxide nanoparticles (ZnO‐NPs) and their application in a wide variety of everyday products. It creates the need for a full assessment of their safety for humans. The aim of the study was to assess the toxic effects of ZnO‐NPs on model human cells of the immune system: U‐937, HL‐60, HUT‐78, and COLO‐720L. Particular attention was paid to the direct interaction of the nanoparticles with membrane lipids and the role of zinc ions in the mechanism of their toxicity. Cell viability, lipid peroxidation, cell membrane integrity, and the amount of zinc ions released from nanoparticles were tested. Disruption in cell metabolism was noted for ZnO‐NPs concentrations from 6.25 mg/L. Contact with ZnO‐NPs caused lipid peroxidation of all cells and correlated with membrane disruption of HL‐60, HUT‐78, and COLO‐720L cells. Model monolayers (Langmuir technique) were used to assess the interaction of the nanoparticles with the studied lipids. Physicochemical parameters, such as the area per molecule at maximal layer compression, the pressure at which the monolayer collapses, and the static compression modulus, were calculated. The models of the HL‐60 and U‐937 cell membranes under ZnO‐NPs treatment reacted in a different way. It has also been shown that Zn2+ are not the main causative factor of ZnO‐NPs toxicity. Investigating the early stages of mechanism of nanoparticles toxicity will allow for a more complete risk assessment and development of methods for a safer synthesis of engineering nanomaterials.